JP2020503296A - 直腸フォーム製剤 - Google Patents

直腸フォーム製剤 Download PDF

Info

Publication number
JP2020503296A
JP2020503296A JP2019531779A JP2019531779A JP2020503296A JP 2020503296 A JP2020503296 A JP 2020503296A JP 2019531779 A JP2019531779 A JP 2019531779A JP 2019531779 A JP2019531779 A JP 2019531779A JP 2020503296 A JP2020503296 A JP 2020503296A
Authority
JP
Japan
Prior art keywords
foam
formulation
propellant
component
anhydrous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019531779A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020503296A5 (https=
Inventor
クリル カスペル ラーセン
クリル カスペル ラーセン
Original Assignee
フェリング ベスローテン フェンノートシャップ
フェリング ベスローテン フェンノートシャップ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by フェリング ベスローテン フェンノートシャップ, フェリング ベスローテン フェンノートシャップ filed Critical フェリング ベスローテン フェンノートシャップ
Publication of JP2020503296A publication Critical patent/JP2020503296A/ja
Publication of JP2020503296A5 publication Critical patent/JP2020503296A5/ja
Priority to JP2022129473A priority Critical patent/JP2022163191A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2019531779A 2016-12-16 2017-12-14 直腸フォーム製剤 Pending JP2020503296A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022129473A JP2022163191A (ja) 2016-12-16 2022-08-16 直腸フォーム製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662435265P 2016-12-16 2016-12-16
US62/435,265 2016-12-16
PCT/IB2017/057954 WO2018109717A1 (en) 2016-12-16 2017-12-14 Rectal foam formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022129473A Division JP2022163191A (ja) 2016-12-16 2022-08-16 直腸フォーム製剤

Publications (2)

Publication Number Publication Date
JP2020503296A true JP2020503296A (ja) 2020-01-30
JP2020503296A5 JP2020503296A5 (https=) 2021-01-28

Family

ID=60937825

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019531779A Pending JP2020503296A (ja) 2016-12-16 2017-12-14 直腸フォーム製剤
JP2022129473A Abandoned JP2022163191A (ja) 2016-12-16 2022-08-16 直腸フォーム製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022129473A Abandoned JP2022163191A (ja) 2016-12-16 2022-08-16 直腸フォーム製剤

Country Status (12)

Country Link
US (1) US20190351060A1 (https=)
EP (1) EP3554473A1 (https=)
JP (2) JP2020503296A (https=)
KR (1) KR20190110092A (https=)
CN (1) CN110430869A (https=)
AU (1) AU2017377017A1 (https=)
BR (1) BR112019012122A2 (https=)
CA (1) CA3046938A1 (https=)
IL (1) IL267347A (https=)
MX (2) MX391415B (https=)
RU (1) RU2757275C2 (https=)
WO (1) WO2018109717A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3216267A1 (en) * 2021-04-22 2022-10-27 Glenn W. Laub Foam compositions for treating clostridioides difficile infections

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04234315A (ja) * 1990-07-27 1992-08-24 Giuliani Spa 直腸投与用薬剤
JPH05504571A (ja) * 1990-02-09 1993-07-15 カビ・フアーマシア・アクチエボラーグ 薬学的用途のための発泡性組成物、その使用および治療方法
JPH09506605A (ja) * 1993-12-14 1997-06-30 スコフィーサ フォーム、特に直腸フォームのための新規組成物、及びこれから得られたフォーム
JP2007503428A (ja) * 2003-08-25 2007-02-22 フォーミックス エルティーディー． 浸透性医薬発泡剤
JP2008539222A (ja) * 2005-04-26 2008-11-13 フォーミックス エルティーディー． ステロイドキット及び起泡性組成物、並びにその使用
JP2008540508A (ja) * 2005-05-09 2008-11-20 フォーミックス エルティーディー． 起泡性ビヒクル及びその医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
DE4446891A1 (de) 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20080069779A1 (en) * 2003-08-04 2008-03-20 Foamix Ltd. Foamable vehicle and vitamin and flavonoid pharmaceutical compositions thereof
WO2009150530A2 (en) * 2008-06-11 2009-12-17 Ferring International Center Sa Novel foam composition
EP2140866A1 (en) * 2008-07-04 2010-01-06 Bayer Schering Pharma Aktiengesellschaft Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract
RU2012126084A (ru) * 2009-11-23 2013-12-27 Сипла Лимитед Пенная композиция для местного применения

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05504571A (ja) * 1990-02-09 1993-07-15 カビ・フアーマシア・アクチエボラーグ 薬学的用途のための発泡性組成物、その使用および治療方法
JPH04234315A (ja) * 1990-07-27 1992-08-24 Giuliani Spa 直腸投与用薬剤
JPH09506605A (ja) * 1993-12-14 1997-06-30 スコフィーサ フォーム、特に直腸フォームのための新規組成物、及びこれから得られたフォーム
JP2007503428A (ja) * 2003-08-25 2007-02-22 フォーミックス エルティーディー． 浸透性医薬発泡剤
JP2008539222A (ja) * 2005-04-26 2008-11-13 フォーミックス エルティーディー． ステロイドキット及び起泡性組成物、並びにその使用
JP2008540508A (ja) * 2005-05-09 2008-11-20 フォーミックス エルティーディー． 起泡性ビヒクル及びその医薬組成物

Also Published As

Publication number Publication date
AU2017377017A1 (en) 2019-07-04
KR20190110092A (ko) 2019-09-27
JP2022163191A (ja) 2022-10-25
WO2018109717A1 (en) 2018-06-21
RU2757275C2 (ru) 2021-10-12
US20190351060A1 (en) 2019-11-21
MX391415B (es) 2025-03-21
CN110430869A (zh) 2019-11-08
BR112019012122A2 (pt) 2019-11-05
CA3046938A1 (en) 2018-06-21
EP3554473A1 (en) 2019-10-23
IL267347A (en) 2019-08-29
RU2019119495A3 (https=) 2021-03-24
MX2019006924A (es) 2019-10-09
RU2019119495A (ru) 2021-01-18
MX2021016053A (es) 2022-02-03

Similar Documents

Publication Publication Date Title
JP5619337B2 (ja) 皮膚残渣を最小限に抑えるための経皮的医薬製剤
JP5184373B2 (ja) 発泡組成物
JP2834951B2 (ja) 細菌性腟症用予防および治療剤
ES2933479T3 (es) Estabilidad mejorada de formulaciones de progestágenos
US20110195114A1 (en) Transdermal delivery systems for active agents
NO329474B1 (no) Topisk, medisinsk spraypreparat, avleveringsinnretning samt fremgangsmater for fremstilling av avleveringsinnretninger.
RU2560879C2 (ru) Cпособ профилактики передающихся половым путем вирусных заболеваний, лекарственное средство, способ получения лекарственного средства, фармацевтическая композиция для местного применения и презерватив
JPH05504571A (ja) 薬学的用途のための発泡性組成物、その使用および治療方法
AU2008289109A1 (en) High concentration local anesthetic formulations
JP2002128699A (ja) 消炎鎮痛外用剤組成物
BR112021002656A2 (pt) composições oleaginosas tópicas
CA3163530A1 (en) Topical composition comprising tofacitinib and fingolimod
JP4585104B2 (ja) 外用消炎鎮痛剤医薬組成物
JP2022163191A (ja) 直腸フォーム製剤
US20050158371A1 (en) Novel external agent
TWI886312B (zh) 磷脂肌醇3-激酶抑制劑的調配物
WO2020022368A1 (ja) 液状外用剤
JPH10158151A (ja) 糖アルコール類配合軟膏剤
US20230149352A1 (en) Uses of apremilast
US8206688B2 (en) Foam-forming composition
WO2007099559A2 (en) Method of preparation for novel composition of 2-{(2,6 dichlorophenyl) amino] benzeneacetic acid carboxymethyl ester or 2-[2-[2-(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid and method of its use
JP4818969B2 (ja) 関節リウマチの痛みに対する鎮痛効果を有する外用剤の薬効評価方法
JP2008231081A (ja) ケトプロフェン含有外用剤
KR20180128450A (ko) 글리코피롤레이트의 국소 스프레이 포뮬레이션
Shenai In-vitro release/permeation studies of fluconazole from vaginal bases and its antifungal activity

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201209

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201209

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210916

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211004

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20211223

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220302

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220420

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220816

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20220816

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20220824

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20220829

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220912

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20230303

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20230308